Connor, Clark & Lunn Investment Management Ltd. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$183,837,000
+29.7%
7,902,892
-11.3%
1.03%
+20.5%
Q1 2018$141,714,000
+20.3%
8,908,077
+58.1%
0.86%
+24.7%
Q4 2017$117,815,000
+18.5%
5,634,222
-19.0%
0.69%
+15.2%
Q3 2017$99,386,000
+17.3%
6,951,722
+42.4%
0.60%
+7.2%
Q2 2017$84,724,000
+421.5%
4,881,613
+231.0%
0.56%
+420.6%
Q1 2017$16,247,000
+236.7%
1,474,996
+343.7%
0.11%
+224.2%
Q4 2016$4,826,000
-91.1%
332,426
-85.0%
0.03%
-91.3%
Q3 2016$54,156,000
+43.1%
2,211,056
+17.2%
0.38%
+36.5%
Q2 2016$37,837,000
-8.6%
1,886,316
+20.0%
0.28%
-13.7%
Q1 2016$41,396,000
-85.3%
1,572,511
-43.4%
0.32%
-86.3%
Q4 2015$280,893,000
-54.8%
2,775,952
-20.6%
2.35%
-53.4%
Q3 2015$621,160,000
-13.0%
3,496,177
+8.7%
5.04%
-22.3%
Q2 2015$713,834,000
+7.1%
3,216,467
-4.6%
6.49%
+15.6%
Q1 2015$666,365,000
+75.6%
3,372,973
+27.7%
5.61%
+83.1%
Q4 2014$379,412,000
+1.3%
2,642,059
-7.4%
3.07%
+1.2%
Q3 2014$374,487,000
-20.3%
2,851,841
-18.1%
3.03%
-8.7%
Q2 2014$469,649,000
-16.1%
3,480,427
-9.5%
3.32%
-18.8%
Q1 2014$559,595,0003,847,6024.09%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2014
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders